Login to Your Account

Talecris Tries IPO Window Again: Aiming for $850M to Pay Off Debt

By Trista Morrison

Wednesday, September 16, 2009
Talecris Biotherapeutics Holdings Corp. is reaching out to grab the initial public offering torch from Cumberland Pharmaceuticals Inc., but the blood products company still faces many of the same issues that drew criticism during its last IPO attempt. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription